{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"pyruvate-dehydrogenase-e3-deficiency","columns":[{"gene":"","key":"population-06a25df7cd98c4841b0f","label":"Dihydrolipoamide dehydrogenase deficiency","mondoId":"MONDO:0009529","onsetQualifier":null,"originColumnKey":"MONDO:0009529/OMIM:246900","originalViews":[{"key":"MONDO:0009529/OMIM:246900","label":"Dihydrolipoamide dehydrogenase deficiency","scopeLabel":"OMIM:246900","sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"recordKeys":["0b131af11e9a8d0224c4bd5eb2c92cb2ca41c66c91b8e2b9a96483a3d99c5a1e","3cfb41cadabcda6b7503b4457ee104dd0551531381adf3adb188ae2d02f5e1ce","4481f04c118433026bc1d28d59941907165628a269397fd3b532080356aeb7ab","46bce106827a29bdf8169a2f02c180f6150104a9822e8477f41ae74b00fc52cd","50c4e7e6c941f34a6aff12e53c4742849719138fbea02281f910f1346c3ba9b7","5133318e208e4677d5828135f7334a5fff7bfba415814f1a5d0f51178ba77280","52338884bd7695fc3a00aec1c72c964979ad3b652faae3efbc27f4a1856973e5","55fba4ffea3cd44bba6977e5d5372006f76e94ab7d7fe13f170d1a5e18d23c21","7289b44b5ed8fcf6c3fd0535449ef00e8325e582f4e7694a227c75dc7a8068c2","73b5f72b5408b773eeb730e53b46a635bf8dab27bda01d6d118858954c00c55e","7ee2b3c00537dc3d6d29b9577806b89b68ec4c33b959c0abf988588c01b82483","8f13edc5ce93ec347c36d30cb105ed9f975d64decefd4748dd86aeaf69078efb","958f22be18239a32e994e551f3465ea9066f7615ebb694c45590af2b4ec6db38","95f80f189d36d9b486d9eceee0b1d95024974871bdf9f4e0e5182d3ca39ababa","aae5c96a6940aaf2092f129dce7dc5aa490a4e4d079c770dcc44e4aa007f93e3","bc6435e834e385f0149d8486ed14ed9bf009f62ae90bd59e389ea4920a200f92","c5825b317218a8e393cb4bbb662eec6f7636e8c81065ad9c546f5dbb8c31ea68","e359e16b3a3fd6b39e94abda07018e90b9c09c137142124c83e800ed8529601f","e4043eb82418eb45a27e258fe2ac93957fd026b23b6b2972839823a15b6396f7","f1d641c90ca8457b9ff39b3d819f69b372c7d22d26cb868575e09476153eec78","fe2d0139278a579397d48563dd29f3d37a9379694312ec95f7cc9e1063653b6b"],"recordQualifiers":{},"scopeLabel":"OMIM:246900","sourceIds":["OMIM:246900"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."},{"gene":"","key":"population-d2c6bc08914cb73adf00","label":"Pyruvate dehydrogenase E3 deficiency","mondoId":"MONDO:0009529","onsetQualifier":null,"originColumnKey":"MONDO:0009529/ORPHA:2394","originalViews":[{"key":"MONDO:0009529/ORPHA:2394","label":"Pyruvate dehydrogenase E3 deficiency","scopeLabel":"ORPHA:2394","sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"recordKeys":["0cfa972a217714456c4c802fbdeaa86751b7d344d45e77f8317191c56be52801","10762b1f67050d4e771d707eeda80e9c3f9c904efeb51c83fdc40a9417592441","1576d68ef2dd201c469a402bae538c942eb9642cb68b0cd9f512c66df6447fd6","2410b5a561c3a734c29a83dbd38256c050c524f0881c413392313e8dfdcb22e6","284c38e2958969db737d960f7949a9e8519b6c98993e276b851de8d2683af602","2deb335031cff0c0d6e3701cba0d396ae70a8b0aa65c9b0ca51765441af26475","39cd6cda141d5f31a389d96a06582a038bde5ab16a4b1446d51046b0e7dd7153","3a7e4af6d6bd9e952ebc172c5426dd250fc1511c3f443ef05c653ac47ea8ca5c","410ca61334f494a8b81778f24e0cd82cf127ccff78adc3039e556d7c0f0d21fb","44bd2947d30a2d193dd5f5b7c82deb3882756d3511c94353375f058e5f9e636a","45a73d3020fbe31efef46e44e2e4528686d73526243b68bbed0d49c89aeac459","4f5fdeb3b0dbec6b0a697d80c30bc9d75f1688c01e7c731bfd6bf56a3448030e","5fd688131ea6444b0eb21a0188a5ccc09d85c68385cca91f59395076cc6e6d00","631fa50bb559fd906a411380b3b77bbf73ffc85a80293bcfe7e34a8cece6fb7e","6c2944f8abbf15fe137f2c2c69c082a53f1c0c83438339f67d3bdef8bb884ac8","72accf9004d3155cdf24e8560bc2a80deb03e0f6b624aa3ed7856645989c33bd","82a0b4ca273fc5d3f192fc68eaeacb3a3b2ab242a8a30f5368e5e7844576453d","975170a22ec62b803c4fcd9138bc77dc7db404ee98cbf2c28b6998784208911f","99e1e9b7c6cd29333fb80f891e2fd42919a5c276c865f8da15ab2d173967c5f1","9b2015029a437b95fa989024830aa2ecec3936d4502cafe1238d371fa312e8c7","add3374be81413a33eefd9a802103f06daed5a7443d9d0d38c1ca00dcbd2927f","ae842ae2f83034ac8f16342ee28c5c14f381196627b94c4049358a1fe1657d11","aede8db87dee3b1596cf5bb95379e81bef09362496ad62eaaa803c7a5a6ac366","c2b1a277c1d66af14202d008300a73a084023ae1909cc9e99085712b48233876","c87a88946dbf34dcfb896956160a0cf96edc4854743705d7500355185f5a628b","deef4b39c9a6838787639e4c47bac69d944a35597384ee34637e508aed73f678","df0c68efb235aa30e1ed14c9a79b20281a1db062d53a4aead1c71dc8ee955607","f967b5cf936f2f91555ab9d8e828fb025b080b0017d11c8edf9cb71459647a2b"],"recordQualifiers":{},"scopeLabel":"ORPHA:2394","sourceIds":["ORPHA:2394"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-06a25df7cd98c4841b0f","population-d2c6bc08914cb73adf00"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0030872","HP:0001251","HP:0000708","HP:0001638","HP:0003234","HP:0001410","HP:0001332"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":8,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":49,"sourceGroups":{"omim":13,"orphanet":28,"published":8}},"features":[{"hpoId":"HP:0030872","label":"Abnormal cardiac ventricular function","primary":true},{"hpoId":"HP:0001251","label":"Ataxia","primary":true},{"hpoId":"HP:0000708","label":"Atypical behavior","primary":true},{"hpoId":"HP:0001638","label":"Cardiomyopathy","primary":true},{"hpoId":"HP:0003234","label":"Decreased circulating carnitine concentration","primary":true},{"hpoId":"HP:0001410","label":"Decreased liver function","primary":true},{"hpoId":"HP:0001332","label":"Dystonia","primary":true},{"hpoId":"HP:0008344","label":"Elevated circulating branched chain amino acid concentration","primary":false},{"hpoId":"HP:0002910","label":"Elevated circulating hepatic transaminase concentration","primary":false},{"hpoId":"HP:0001298","label":"Encephalopathy","primary":false},{"hpoId":"HP:0001508","label":"Failure to thrive","primary":false},{"hpoId":"HP:0011968","label":"Feeding difficulties","primary":false},{"hpoId":"HP:0001290","label":"Generalized hypotonia","primary":false},{"hpoId":"HP:0001263","label":"Global developmental delay","primary":false},{"hpoId":"HP:0002480","label":"Hepatic encephalopathy","primary":false},{"hpoId":"HP:0001399","label":"Hepatic failure","primary":false},{"hpoId":"HP:0002240","label":"Hepatomegaly","primary":false},{"hpoId":"HP:0001987","label":"Hyperammonemia","primary":false},{"hpoId":"HP:0100724","label":"Hypercoagulability","primary":false},{"hpoId":"HP:0010913","label":"Hyperisoleucinemia","primary":false},{"hpoId":"HP:0001639","label":"Hypertrophic cardiomyopathy","primary":false},{"hpoId":"HP:0001943","label":"Hypoglycemia","primary":false},{"hpoId":"HP:0001252","label":"Hypotonia","primary":false},{"hpoId":"HP:0002151","label":"Increased circulating lactate concentration","primary":false},{"hpoId":"HP:0003542","label":"Increased circulating pyruvate concentration","primary":false},{"hpoId":"HP:0500193","label":"Increased CSF isoleucine concentration","primary":false},{"hpoId":"HP:0500191","label":"Increased CSF leucine concentration","primary":false},{"hpoId":"HP:0500187","label":"Increased CSF valine concentration","primary":false},{"hpoId":"HP:0012402","label":"Increased urine alpha-ketoglutarate concentration","primary":false},{"hpoId":"HP:0001993","label":"Ketoacidosis","primary":false},{"hpoId":"HP:0003128","label":"Lactic acidosis","primary":false},{"hpoId":"HP:0001254","label":"Lethargy","primary":false},{"hpoId":"HP:0001942","label":"Metabolic acidosis","primary":false},{"hpoId":"HP:0000252","label":"Microcephaly","primary":false},{"hpoId":"HP:0003394","label":"Muscle spasm","primary":false},{"hpoId":"HP:0012758","label":"Neurodevelopmental delay","primary":false},{"hpoId":"HP:0007663","label":"Reduced visual acuity","primary":false},{"hpoId":"HP:0001250","label":"Seizure","primary":false},{"hpoId":"HP:0001257","label":"Spasticity","primary":false},{"hpoId":"HP:0002013","label":"Vomiting","primary":false}],"ledeHtml":"Dihydrolipoamide dehydrogenase deficiency is a severe condition that can affect several body systems. Signs and symptoms of this condition usually appear shortly after birth, and they can vary widely among affected individuals. A common feature of dihydrolipoamide dehydrogenase deficiency is a potentially life-threatening buildup of lactic acid in tissues (lactic acidosis), which can cause nausea, vomiting, severe breathing problems, and an abnormal heartbeat. Neurological problems are also common in this condition; the first symptoms in affected infants are often decreased muscle tone (hypotonia) and extreme tiredness (lethargy). As the problems worsen, affected infants can have difficulty feeding, decreased alertness, and seizures. Liver problems can also occur in dihydrolipoamide dehydrogenase deficiency, ranging from an enlarged liver (hepatomegaly) to life-threatening liver failure. In some affected people, liver disease, which can begin anytime from infancy to adulthood, is the primary symptom. The liver problems are usually associated with recurrent vomiting and abdominal pain. Rarely, people with dihydrolipoamide dehydrogenase deficiency experience weakness of the muscles used for movement (skeletal muscles), particularly during exercise; droopy eyelids; or a weakened heart muscle (cardiomyopathy). Other features of this condition include excess ammonia in the blood (hyperammonemia), a buildup of molecules called ketones in the body (ketoacidosis), or low blood glucose levels (hypoglycemia). Typically, the signs and symptoms of dihydrolipoamide dehydrogenase deficiency occur in episodes that may be triggered by fever, injury, or other stresses on the body. Affected individuals are usually symptom-free between episodes. Many infants with this condition do not survive the first few years of life because of the severity of these episodes. Affected individuals who survive past early childhood often have delayed growth and neurological problems, including intellectual disability, muscle stiffness (spasticity), difficulty coordinating movements (ataxia), and seizures.","mondoId":"MONDO:0009529","node":{"canonicalSlug":"pyruvate-dehydrogenase-e3-deficiency","comparisons":[{"documentSha256":"c0d095dfa32d6e044d990e97689d6d28de973486ebbae7fc0945e9e701c9239d","key":"legacy-pyruvate-dehydrogenase-e3-deficiency","kind":"legacy","label":"pyruvate dehydrogenase E3 deficiency","memberIds":["MONDO:0009529"],"mondoId":"MONDO:0009529","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/pyruvate-dehydrogenase-e3-deficiency.c0d095dfa32d6e044d990e97689d6d28de973486ebbae7fc0945e9e701c9239d.json"},{"documentSha256":"7cb024a9449023efe42e82f751fc8050beb60f904b4c56bea1d2faada91f9701","key":"expanded-inherited-lipoic-acid-biosynthesis-defect","kind":"expanded","label":"inherited lipoic acid biosynthesis defect","memberIds":["MONDO:0009529","MONDO:0011582","MONDO:0013675","MONDO:0013762","MONDO:0014132","MONDO:0014576","MONDO:0014611","MONDO:0014803","MONDO:0015003","MONDO:0017338","MONDO:0018424","MONDO:0020714","MONDO:0033282","MONDO:0054785","MONDO:0060582","MONDO:0957382","MONDO:0971174","MONDO:0975806"],"mondoId":"MONDO:0018424","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/node-comparison-7cb024a9449023efe42e.7cb024a9449023efe42e82f751fc8050beb60f904b4c56bea1d2faada91f9701.json"},{"documentSha256":"ce5c68ac4abd3ab18d317d100507121049d281ddaf75bd4609c19b7dcf45e881","key":"expanded-maple-syrup-urine-disease","kind":"expanded","label":"maple syrup urine disease","memberIds":["MONDO:0009529","MONDO:0009563","MONDO:0014057","MONDO:0017051","MONDO:0017052","MONDO:0017053","MONDO:0017054","MONDO:0023691","MONDO:0023692","MONDO:0023693"],"mondoId":"MONDO:0009563","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/node-comparison-ce5c68ac4abd3ab18d31.ce5c68ac4abd3ab18d317d100507121049d281ddaf75bd4609c19b7dcf45e881.json"},{"documentSha256":"53240157b8fc0ff8fc8e0c8db5b203b04baf0545bbdca3da0e781042ebf59e5d","key":"expanded-pyruvate-dehydrogenase-deficiency","kind":"expanded","label":"pyruvate dehydrogenase deficiency","memberIds":["MONDO:0009502","MONDO:0009503","MONDO:0009529","MONDO:0010717","MONDO:0012120","MONDO:0013580","MONDO:0013762","MONDO:0019169"],"mondoId":"MONDO:0019169","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/node-comparison-53240157b8fc0ff8fc8e.53240157b8fc0ff8fc8e0c8db5b203b04baf0545bbdca3da0e781042ebf59e5d.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"summary","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Pyruvate dehydrogenase E3 deficiency","originalSourceId":"ORPHA:2394","paragraphs":["Dihydrolipoamide dehydrogenase deficiency is a severe condition that can affect several body systems. Signs and symptoms of this condition usually appear shortly after birth, and they can vary widely among affected individuals. A common feature of dihydrolipoamide dehydrogenase deficiency is a potentially life-threatening buildup of lactic acid in tissues (lactic acidosis), which can cause nausea, vomiting, severe breathing problems, and an abnormal heartbeat. Neurological problems are also common in this condition; the first symptoms in affected infants are often decreased muscle tone (hypotonia) and extreme tiredness (lethargy). As the problems worsen, affected infants can have difficulty feeding, decreased alertness, and seizures. Liver problems can also occur in dihydrolipoamide dehydrogenase deficiency, ranging from an enlarged liver (hepatomegaly) to life-threatening liver failure. In some affected people, liver disease, which can begin anytime from infancy to adulthood, is the primary symptom. The liver problems are usually associated with recurrent vomiting and abdominal pain. Rarely, people with dihydrolipoamide dehydrogenase deficiency experience weakness of the muscles used for movement (skeletal muscles), particularly during exercise; droopy eyelids; or a weakened heart muscle (cardiomyopathy). Other features of this condition include excess ammonia in the blood (hyperammonemia), a buildup of molecules called ketones in the body (ketoacidosis), or low blood glucose levels (hypoglycemia). Typically, the signs and symptoms of dihydrolipoamide dehydrogenase deficiency occur in episodes that may be triggered by fever, injury, or other stresses on the body. Affected individuals are usually symptom-free between episodes. Many infants with this condition do not survive the first few years of life because of the severity of these episodes. Affected individuals who survive past early childhood often have delayed growth and neurological problems, including intellectual disability, muscle stiffness (spasticity), difficulty coordinating movements (ataxia), and seizures."],"rawAttribution":"MONDO:0009529","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-21T17:04:26Z","upstream":"GARD:0003263","url":"https://rarediseases.info.nih.gov/diseases/3263"},"ownColumnKeys":["population-06a25df7cd98c4841b0f","population-d2c6bc08914cb73adf00"],"publication":"published","relationships":[{"kind":"parent","label":"maple syrup urine disease","mondoId":"MONDO:0009563","slug":"maple-syrup-urine-disease"},{"kind":"parent","label":"inherited lipoic acid biosynthesis defect","mondoId":"MONDO:0018424","slug":"inherited-lipoic-acid-biosynthesis-defect"},{"kind":"parent","label":"pyruvate dehydrogenase deficiency","mondoId":"MONDO:0019169","slug":"pyruvate-dehydrogenase-deficiency"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"synonym-scope-not-retained","source":"MedlinePlus","url":"https://medlineplus.gov/genetics/condition/dihydrolipoamide-dehydrogenase-deficiency"}],"translation":"pending"},"records":[{"frequencyKind":"count","key":"0b131af11e9a8d0224c4bd5eb2c92cb2ca41c66c91b8e2b9a96483a3d99c5a1e","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:246900","disease_name":"Dihydrolipoamide dehydrogenase deficiency","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0500191","is_excluded":false,"label":"Increased CSF leucine concentration","onset_id":null,"reference":"PMID:8506365","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"0cfa972a217714456c4c802fbdeaa86751b7d344d45e77f8317191c56be52801","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:2394","disease_name":"Pyruvate dehydrogenase E3 deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0008344","is_excluded":false,"label":"Elevated circulating branched chain amino acid concentration","onset_id":null,"reference":"ORPHA:2394","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"10762b1f67050d4e771d707eeda80e9c3f9c904efeb51c83fdc40a9417592441","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:2394","disease_name":"Pyruvate dehydrogenase E3 deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0012402","is_excluded":false,"label":"Increased urine alpha-ketoglutarate concentration","onset_id":null,"reference":"ORPHA:2394","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"1576d68ef2dd201c469a402bae538c942eb9642cb68b0cd9f512c66df6447fd6","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:2394","disease_name":"Pyruvate dehydrogenase E3 deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0030872","is_excluded":false,"label":"Abnormal cardiac ventricular function","onset_id":null,"reference":"ORPHA:2394","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"2410b5a561c3a734c29a83dbd38256c050c524f0881c413392313e8dfdcb22e6","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:2394","disease_name":"Pyruvate dehydrogenase E3 deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001987","is_excluded":false,"label":"Hyperammonemia","onset_id":null,"reference":"ORPHA:2394","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"284c38e2958969db737d960f7949a9e8519b6c98993e276b851de8d2683af602","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:2394","disease_name":"Pyruvate dehydrogenase E3 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0002013","is_excluded":false,"label":"Vomiting","onset_id":null,"reference":"ORPHA:2394","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"2deb335031cff0c0d6e3701cba0d396ae70a8b0aa65c9b0ca51765441af26475","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:2394","disease_name":"Pyruvate dehydrogenase E3 deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0007663","is_excluded":false,"label":"Reduced visual acuity","onset_id":null,"reference":"ORPHA:2394","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"39cd6cda141d5f31a389d96a06582a038bde5ab16a4b1446d51046b0e7dd7153","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:2394","disease_name":"Pyruvate dehydrogenase E3 deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001943","is_excluded":false,"label":"Hypoglycemia","onset_id":null,"reference":"ORPHA:2394","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"3a7e4af6d6bd9e952ebc172c5426dd250fc1511c3f443ef05c653ac47ea8ca5c","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:2394","disease_name":"Pyruvate dehydrogenase E3 deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0003394","is_excluded":false,"label":"Muscle spasm","onset_id":null,"reference":"ORPHA:2394","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"3cfb41cadabcda6b7503b4457ee104dd0551531381adf3adb188ae2d02f5e1ce","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:246900","disease_name":"Dihydrolipoamide dehydrogenase deficiency","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001639","is_excluded":false,"label":"Hypertrophic cardiomyopathy","onset_id":null,"reference":"OMIM:246900","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"410ca61334f494a8b81778f24e0cd82cf127ccff78adc3039e556d7c0f0d21fb","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:2394","disease_name":"Pyruvate dehydrogenase E3 deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002240","is_excluded":false,"label":"Hepatomegaly","onset_id":null,"reference":"ORPHA:2394","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"4481f04c118433026bc1d28d59941907165628a269397fd3b532080356aeb7ab","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:246900","disease_name":"Dihydrolipoamide dehydrogenase deficiency","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0003542","is_excluded":false,"label":"Increased circulating pyruvate concentration","onset_id":null,"reference":"PMID:8506365","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"44bd2947d30a2d193dd5f5b7c82deb3882756d3511c94353375f058e5f9e636a","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:2394","disease_name":"Pyruvate dehydrogenase E3 deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001257","is_excluded":false,"label":"Spasticity","onset_id":null,"reference":"ORPHA:2394","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"45a73d3020fbe31efef46e44e2e4528686d73526243b68bbed0d49c89aeac459","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:2394","disease_name":"Pyruvate dehydrogenase E3 deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0010913","is_excluded":false,"label":"Hyperisoleucinemia","onset_id":null,"reference":"ORPHA:2394","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"46bce106827a29bdf8169a2f02c180f6150104a9822e8477f41ae74b00fc52cd","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:246900","disease_name":"Dihydrolipoamide dehydrogenase deficiency","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001251","is_excluded":false,"label":"Ataxia","onset_id":null,"reference":"OMIM:246900","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"4f5fdeb3b0dbec6b0a697d80c30bc9d75f1688c01e7c731bfd6bf56a3448030e","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:2394","disease_name":"Pyruvate dehydrogenase E3 deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0100724","is_excluded":false,"label":"Hypercoagulability","onset_id":null,"reference":"ORPHA:2394","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"50c4e7e6c941f34a6aff12e53c4742849719138fbea02281f910f1346c3ba9b7","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:246900","disease_name":"Dihydrolipoamide dehydrogenase deficiency","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0001332","is_excluded":false,"label":"Dystonia","onset_id":null,"reference":"PMID:8506365","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"5133318e208e4677d5828135f7334a5fff7bfba415814f1a5d0f51178ba77280","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:246900","disease_name":"Dihydrolipoamide dehydrogenase deficiency","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0002910","is_excluded":false,"label":"Elevated circulating hepatic transaminase concentration","onset_id":null,"reference":"PMID:8506365","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"52338884bd7695fc3a00aec1c72c964979ad3b652faae3efbc27f4a1856973e5","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:246900","disease_name":"Dihydrolipoamide dehydrogenase deficiency","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001250","is_excluded":false,"label":"Seizure","onset_id":null,"reference":"OMIM:246900","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"55fba4ffea3cd44bba6977e5d5372006f76e94ab7d7fe13f170d1a5e18d23c21","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:246900","disease_name":"Dihydrolipoamide dehydrogenase deficiency","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0500187","is_excluded":false,"label":"Increased CSF valine concentration","onset_id":null,"reference":"PMID:8506365","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"5fd688131ea6444b0eb21a0188a5ccc09d85c68385cca91f59395076cc6e6d00","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:2394","disease_name":"Pyruvate dehydrogenase E3 deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0003234","is_excluded":false,"label":"Decreased circulating carnitine concentration","onset_id":null,"reference":"ORPHA:2394","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"631fa50bb559fd906a411380b3b77bbf73ffc85a80293bcfe7e34a8cece6fb7e","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:2394","disease_name":"Pyruvate dehydrogenase E3 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0012758","is_excluded":false,"label":"Neurodevelopmental delay","onset_id":null,"reference":"ORPHA:2394","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"6c2944f8abbf15fe137f2c2c69c082a53f1c0c83438339f67d3bdef8bb884ac8","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:2394","disease_name":"Pyruvate dehydrogenase E3 deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000708","is_excluded":false,"label":"Atypical behavior","onset_id":null,"reference":"ORPHA:2394","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"7289b44b5ed8fcf6c3fd0535449ef00e8325e582f4e7694a227c75dc7a8068c2","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:246900","disease_name":"Dihydrolipoamide dehydrogenase deficiency","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0000252","is_excluded":false,"label":"Microcephaly","onset_id":null,"reference":"OMIM:246900","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"72accf9004d3155cdf24e8560bc2a80deb03e0f6b624aa3ed7856645989c33bd","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:2394","disease_name":"Pyruvate dehydrogenase E3 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0002151","is_excluded":false,"label":"Increased circulating lactate concentration","onset_id":null,"reference":"ORPHA:2394","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"73b5f72b5408b773eeb730e53b46a635bf8dab27bda01d6d118858954c00c55e","raw":{"aspect":"P","body_system":"digestive","disease_id":"OMIM:246900","disease_name":"Dihydrolipoamide dehydrogenase deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002240","is_excluded":false,"label":"Hepatomegaly","onset_id":null,"reference":"OMIM:246900","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"7ee2b3c00537dc3d6d29b9577806b89b68ec4c33b959c0abf988588c01b82483","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:246900","disease_name":"Dihydrolipoamide dehydrogenase deficiency","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0001252","is_excluded":false,"label":"Hypotonia","onset_id":null,"reference":"PMID:8506365","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"82a0b4ca273fc5d3f192fc68eaeacb3a3b2ab242a8a30f5368e5e7844576453d","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:2394","disease_name":"Pyruvate dehydrogenase E3 deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001399","is_excluded":false,"label":"Hepatic failure","onset_id":null,"reference":"ORPHA:2394","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"8f13edc5ce93ec347c36d30cb105ed9f975d64decefd4748dd86aeaf69078efb","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:246900","disease_name":"Dihydrolipoamide dehydrogenase deficiency","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0500193","is_excluded":false,"label":"Increased CSF isoleucine concentration","onset_id":null,"reference":"PMID:8506365","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"958f22be18239a32e994e551f3465ea9066f7615ebb694c45590af2b4ec6db38","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:246900","disease_name":"Dihydrolipoamide dehydrogenase deficiency","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0003128","is_excluded":false,"label":"Lactic acidosis","onset_id":null,"reference":"OMIM:246900","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"95f80f189d36d9b486d9eceee0b1d95024974871bdf9f4e0e5182d3ca39ababa","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:246900","disease_name":"Dihydrolipoamide dehydrogenase deficiency","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001943","is_excluded":false,"label":"Hypoglycemia","onset_id":null,"reference":"OMIM:246900","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"975170a22ec62b803c4fcd9138bc77dc7db404ee98cbf2c28b6998784208911f","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:2394","disease_name":"Pyruvate dehydrogenase E3 deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001254","is_excluded":false,"label":"Lethargy","onset_id":null,"reference":"ORPHA:2394","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"99e1e9b7c6cd29333fb80f891e2fd42919a5c276c865f8da15ab2d173967c5f1","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:2394","disease_name":"Pyruvate dehydrogenase E3 deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001250","is_excluded":false,"label":"Seizure","onset_id":null,"reference":"ORPHA:2394","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"9b2015029a437b95fa989024830aa2ecec3936d4502cafe1238d371fa312e8c7","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:2394","disease_name":"Pyruvate dehydrogenase E3 deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002910","is_excluded":false,"label":"Elevated circulating hepatic transaminase concentration","onset_id":null,"reference":"ORPHA:2394","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"aae5c96a6940aaf2092f129dce7dc5aa490a4e4d079c770dcc44e4aa007f93e3","raw":{"aspect":"P","body_system":"digestive","disease_id":"OMIM:246900","disease_name":"Dihydrolipoamide dehydrogenase deficiency","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0011968","is_excluded":false,"label":"Feeding difficulties","onset_id":null,"reference":"OMIM:246900","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"add3374be81413a33eefd9a802103f06daed5a7443d9d0d38c1ca00dcbd2927f","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:2394","disease_name":"Pyruvate dehydrogenase E3 deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000252","is_excluded":false,"label":"Microcephaly","onset_id":null,"reference":"ORPHA:2394","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"ae842ae2f83034ac8f16342ee28c5c14f381196627b94c4049358a1fe1657d11","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:2394","disease_name":"Pyruvate dehydrogenase E3 deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001638","is_excluded":false,"label":"Cardiomyopathy","onset_id":null,"reference":"ORPHA:2394","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"aede8db87dee3b1596cf5bb95379e81bef09362496ad62eaaa803c7a5a6ac366","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:2394","disease_name":"Pyruvate dehydrogenase E3 deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002480","is_excluded":false,"label":"Hepatic encephalopathy","onset_id":null,"reference":"ORPHA:2394","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"bc6435e834e385f0149d8486ed14ed9bf009f62ae90bd59e389ea4920a200f92","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:246900","disease_name":"Dihydrolipoamide dehydrogenase deficiency","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0001993","is_excluded":false,"label":"Ketoacidosis","onset_id":null,"reference":"PMID:8506365","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"c2b1a277c1d66af14202d008300a73a084023ae1909cc9e99085712b48233876","raw":{"aspect":"P","body_system":"growth","disease_id":"ORPHA:2394","disease_name":"Pyruvate dehydrogenase E3 deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001508","is_excluded":false,"label":"Failure to thrive","onset_id":null,"reference":"ORPHA:2394","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"c5825b317218a8e393cb4bbb662eec6f7636e8c81065ad9c546f5dbb8c31ea68","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:246900","disease_name":"Dihydrolipoamide dehydrogenase deficiency","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001942","is_excluded":false,"label":"Metabolic acidosis","onset_id":null,"reference":"OMIM:246900","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"c87a88946dbf34dcfb896956160a0cf96edc4854743705d7500355185f5a628b","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:2394","disease_name":"Pyruvate dehydrogenase E3 deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001251","is_excluded":false,"label":"Ataxia","onset_id":null,"reference":"ORPHA:2394","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"deef4b39c9a6838787639e4c47bac69d944a35597384ee34637e508aed73f678","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:2394","disease_name":"Pyruvate dehydrogenase E3 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001290","is_excluded":false,"label":"Generalized hypotonia","onset_id":null,"reference":"ORPHA:2394","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"df0c68efb235aa30e1ed14c9a79b20281a1db062d53a4aead1c71dc8ee955607","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:2394","disease_name":"Pyruvate dehydrogenase E3 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0003128","is_excluded":false,"label":"Lactic acidosis","onset_id":null,"reference":"ORPHA:2394","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"e359e16b3a3fd6b39e94abda07018e90b9c09c137142124c83e800ed8529601f","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:246900","disease_name":"Dihydrolipoamide dehydrogenase deficiency","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001298","is_excluded":false,"label":"Encephalopathy","onset_id":null,"reference":"OMIM:246900","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"e4043eb82418eb45a27e258fe2ac93957fd026b23b6b2972839823a15b6396f7","raw":{"aspect":"P","body_system":"digestive","disease_id":"OMIM:246900","disease_name":"Dihydrolipoamide dehydrogenase deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001410","is_excluded":false,"label":"Decreased liver function","onset_id":null,"reference":"OMIM:246900","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"f1d641c90ca8457b9ff39b3d819f69b372c7d22d26cb868575e09476153eec78","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:246900","disease_name":"Dihydrolipoamide dehydrogenase deficiency","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001254","is_excluded":false,"label":"Lethargy","onset_id":null,"reference":"OMIM:246900","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"f967b5cf936f2f91555ab9d8e828fb025b080b0017d11c8edf9cb71459647a2b","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:2394","disease_name":"Pyruvate dehydrogenase E3 deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0011968","is_excluded":false,"label":"Feeding difficulties","onset_id":null,"reference":"ORPHA:2394","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"fe2d0139278a579397d48563dd29f3d37a9379694312ec95f7cc9e1063653b6b","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:246900","disease_name":"Dihydrolipoamide dehydrogenase deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001263","is_excluded":false,"label":"Global developmental delay","onset_id":null,"reference":"OMIM:246900","source_release":"2026-06-23"},"sourceGroups":["omim"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/3263\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0009529\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>GARD:0003263</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Dihydrolipoamide dehydrogenase deficiency is a severe condition that can affect several body systems. Signs and symptoms of this condition usually appear shortly after birth, and they can vary widely among affected individuals. A common feature of dihydrolipoamide dehydrogenase deficiency is a potentially life-threatening buildup of lactic acid in tissues (lactic acidosis), which can cause nausea, vomiting, severe breathing problems, and an abnormal heartbeat. Neurological problems are also common in this condition; the first symptoms in affected infants are often decreased muscle tone (hypotonia) and extreme tiredness (lethargy). As the problems worsen, affected infants can have difficulty feeding, decreased alertness, and seizures. Liver problems can also occur in dihydrolipoamide dehydrogenase deficiency, ranging from an enlarged liver (hepatomegaly) to life-threatening liver failure. In some affected people, liver disease, which can begin anytime from infancy to adulthood, is the primary symptom. The liver problems are usually associated with recurrent vomiting and abdominal pain. Rarely, people with dihydrolipoamide dehydrogenase deficiency experience weakness of the muscles used for movement (skeletal muscles), particularly during exercise; droopy eyelids; or a weakened heart muscle (cardiomyopathy). Other features of this condition include excess ammonia in the blood (hyperammonemia), a buildup of molecules called ketones in the body (ketoacidosis), or low blood glucose levels (hypoglycemia). Typically, the signs and symptoms of dihydrolipoamide dehydrogenase deficiency occur in episodes that may be triggered by fever, injury, or other stresses on the body. Affected individuals are usually symptom-free between episodes. Many infants with this condition do not survive the first few years of life because of the severity of these episodes. Affected individuals who survive past early childhood often have delayed growth and neurological problems, including intellectual disability, muscle stiffness (spasticity), difficulty coordinating movements (ataxia), and seizures.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/3263\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Overview"}],"sharedSources":[],"slug":"pyruvate-dehydrogenase-e3-deficiency","sourceDocuments":[{"name":"GARD: Pyruvate dehydrogenase E3 deficiency","reviewed":null,"source_release":"2026-10-21T17:04:26Z","url":"https://rarediseases.info.nih.gov/diseases/3263"},{"name":"MONDO: pyruvate dehydrogenase E3 deficiency","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0009529"}],"sourceNote":"","synonyms":["dihydrolipoamide dehydrogenase deficiency","DLD deficiency","DLDD","E3-deficient maple syrup urine disease","maple syrup urine disease, type III","pyruvate dehydrogenase E3 deficiency"],"takeawayHtml":"","title":"pyruvate dehydrogenase E3 deficiency"},"schemaVersion":1}
